Glycoprotein (GP)llb/llla, an integrin complex found on the surface of platelets, is a receptor for fibrinogen and other ligands, and is involved in platelet aggregation. Because GPllb is specifically expressed in megakaryocytes, we have studied the 5'-flanking region of the rat (r) GPllb gene as a model of a megakaryocyte-specific gene. The studies presented here used a rat marrow expression system, which allows the study of primary cells undergoing terminal differentiation into megakaryocytes. The determination of megakaryocyte-specific expression of DNA constructs was possible by immunomagnetically separating megakaryocytes from total bone marrow cells. Transient expression constructs, containing varying lengths of the 5"flanking region from -39 t o -912 bp, localized a regulatory element between -460 and -439 bp upstream of the transcriptional start site. This region contains a GATA consensus binding element , ).
LYCOPROTEIN (GP)IIb is the a-subunit of the GPIIW
IIIa complex on platelets.' This complex is a member of the integrin family of cell surface receptors and binds fibrinogen, vitronectin, von Willebrand factor, and fibronectin when platelets are activated. It is involved in the formation of the initial platelet plug and is present at high levels on the platelet surface (50,000 copies per platelet).' GPIIb is expressed at an early stage in megakaryocytes and in no other cell type, but GPIIIa is found in many different cell types.3" Because of its high-level megakaryocyte-specific expression, GPIIb may be useful as a model for gene regulation of a megakaryocyte-specific gene, by identification of lineage-specific factors that bind to cis-acting elements. This information should allow us to learn more about the commitment of hematopoietic precursors to megakaryocytopoiesis.
Potential regulatory domains in the 5"flanking region of the human (h) GPIIb gene involved in expression were described using DNase I footprinting and expression s t u d i e~.~,~ These studies were performed in HEL cells, a human erythroleukemic cell line with some megakaryocytic properties.
Six footprinting domains were defined in the first 600 bp of 5"flanking regions, domains A through F (Fig 1A) . Of these domains, A, D, and E were shown to be lineage-specific in gel shift assays with various cell lines. Further, chloramphenicol acetyltransferase (CAT) reporter gene studies with the human 5'-flanking region, in HEL cells, demonstrated that each of these domains only modestly promoted expression, with expression level changes being about threefold* for each domain ( Fig 1A) .
Domain A contains a GATA-binding consensus sequence at -54, which is adjacent to a complement Ets-binding consensus sequence." Domain D contains a GATA-binding consensus sequence at -454, and domain E contains an Etsbinding consensus sequence. A family of nuclear regulatory proteins that recognize the core sequence GATA has been described. This family includes GATA-1 and GATA-2,
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Blood, Vol84, No 10 (November 15). 1994 pp [3385] [3386] [3387] [3388] [3389] [3390] [3391] [3392] [3393] the GAT&, demonstrated that this region was essential for full expression, which suggests that this region may interact with the GAT& site in promoting high-level lineage-specific expression. To define regulatory elements between the GAT& and the transcriptional start site further, we tested additional constructs derived from the original -912 construct; each of which contained the GAT& but had different 50-bp deletions from -450 to the start site. Virtually all of these constructs continued t o show high-level tissuespecific expression. The deleted -150 t o -101 construct had twice the level of expression of the full-length wild-type construct; therefore, this region may contain a negative regulatory element. Comparison of our data with expression studies performed with the 5"region of the human GPllb gene using HEL cells, a cell line with some megakaryocytic properties, demonstrates significant differences, which may reflect our use of primary rat bone marrow cells. In particular, our study points to the importance of the GATA-for high levels of GPllb expression in developing megakaryocytes. 0 1994 by The American Society of Hematology.
which are thought to be important regulators of gene transcription in erythroid, megakaryocytic, and mast cells."3'' It is not yet clear whether GATA-1 or GATA-2 play critical roles in GPIIb gene expression during megakaryocytopoie~is.'~ The Ets family of transcription factors have been shown to be involved in differentiation and development in a variety of species14 and are also thought to be important for gene regulation during hematop~iesis.'~"~. PU. 1, a member of this family, has recently been shown to be present in megakaryocytes by immunohist~chemistry.'~ Thus, it seems reasonable to expect that studies of the 5"flanking region of the GPIIb gene would demonstrate important roles for sequence domains that may be binding sites for these nuclear regulatory proteins.
While studies were underway with the 5"flanking region of the hGPIIb gene using HEL cells, we had presented in preliminary fashion our data with the 5'-flanking region of the rat (r) GPIIb gene studied in a primary rat marrow sys- tern.*".*' This system2* was used because it allowed studies of the tissue-specific expression of the rGPIIb 5'-flanking region in megakaryocyte precursors undergoing normal differentiation into megakaryocytes. It was anticipated that regulatory regions would be conserved across species and that domains of biologic importance in the regulation of gene expression would be preserved.
We have previously published a partial sequence of the 5'-flanking and untranslated regions of the rGPIIb gene and showed that the sequence is well preserved near the transcriptional start site when compared with its human counterpart. 23 In the present study, using the rat marrow expression system, we confirm the human data that domain E exerts a minimal (twofold to threefold) effect on gene expression. However, we show that domain A has a more potent effect (-15-fold) and that the GATA sequence in domain D is a very potent regulator of GPIIb expression (-50-fold). Furthermore, we demonstrate that a region immediately downstream from this domain also acts as a strong positive regulatory element. A potential suppressor site between -150 and -101 is also defined. These studies provide further insights into the regulatory elements involved in megakaryocyte-specific expression of the GPIIb gene.
MATERIALS AND METHODS
Subcloning and characterization of the 5':jIanking region of the rGPffb gene. 5"GPIIb genomic clones were isolated from a partial Sau3A rat genomic library in EMBL3A as described previously. 24 For personal use only. A 2.2-kb SsrT restriction fragment was then subcloned into linearized M13mp18. The S'-flanking region of rGPIIb ("1.1 kb) was sequenced using the dideoxy chain termination technique. 25 The rat S'-flanking region sequence was compared with the human S'-flanking sequence using sequence comparison software, described below. Plasmid construction. The full-length 912-bp construct was made by overlap amplification,z6 a polymerase chain reaction (PCR) technique, which fused 912 bp of the S'-flanking region plus the S'-untranslated region of the rGPlIb gene directly in front of the initiating methionine of the human growth hormone (hGH) gene in pOGH (Nichols Institute Diagnostics, San Juan Capistrano, CA) (Fig 2) . The necessary portion of the hGH gene was amplified from the pOGH vector using a S' primer containing a portion of the S'-untranslated (S'UT) region of the rGPIlb gene fused to the beginning of the coding region of the hGH gene. The 3' primer was located downstream of an SsfI site in pOGH. Nine hundred twelve base pairs of the rat 5"flanking region was amplified from the 2.2-kb SstT fragment of the rGPIIb gene in single-stranded M1 3mp18, described above, using a S' primer containing an artificial BumHI site near its S' end. The 3' primer is the complementary sequence of the S'UT region of the rGPIIb gene. These two PCR products were then annealed and reamplified with the two outermost primers: the S' 912 primer with the BamHI site and the 3' primer located downstream of the SstI in the pOGH vector. The product was then cut with BumHI and SstI and ligated into a similarly cut pOGH vector. Initial constructs were made with Taq polymerase (Promega, Madison, WI), while later constructs were made with Vent polymerase (New England Biolabs, Beverly, MA) to reduce PCR-induced mutation^.^' All PCR-derived constructs were sequenced to determine if there were any PCR-induced mutations. Additional truncation constructs described in this report were made in a similar fashion. Point mutations and deletions were inserted into the full-length, wild-type construct using recombinant PCR,2h,28 in which two rounds of PCR are performed: the first round results in overlapping PCR products, each of which contains the mutation of interest; and the second round results in a full-length PCR product, with the mutation of interest within it. The control DNA fragment for the Hirt assay, described below, was generated by cutting a construct that was not used in the experiment under consideration, and which generated a BamHI/ S.rt1 fragment that was different in size from the constructs under consideration.
Cell culture and electroporation. Rat bone marrow cells were isolated essentially as previously described." Femurs and tibias isolated from C02-narcotized rats (-400 g) were placed into cold CATCH medium (Hank's balanced salt solution [no. Ca2+ or Mg"], 0.38% Na citrate, 1 mmol/L adenosine, 2 mmol/L theophylline, S% fetal bovine serum, pH 7.4). Marrow cells were flushed out of the bones using an 18-gauge needle filled with CATCH medium (S mL per femur and tibia). Marrow cells were dispersed in CATCH medium with a syringe and filtered through a 100-to 200-pm mesh nylon filter (Tetko, New York, NY). The cells were pelleted at 400 X g for S minutes, resuspended in an equal volume of lysis buffer (Tris Base 2.06 g/L, NH,CI 7.5 g/L), and incubated at 37°C for 10 minutes to lyse red blood cells. Cells were then pelleted as above, washed twice with CATCH medium, and the total yield of nucleated cells determined. The remaining cells were resuspended in electroporation buffer (30.8 mmol/L NaCI, 120.7 mmol/L KC1, 8.1 mmol/ L Na2HP04, 1.46 mmol/L KH2P04, S mmol/L MgC12). One hundred micrograms of circular plasmid DNA was added to 25 X 10" rat bone marrow cells in 0.4-cm cuvettes. This amount of DNA was comparable with that used in previous studies." The cells were incubated on ice for I S minutes and then electroporated (Cell-Porator; Life Technologies, Gaithersburg, MD) at 230 V and 800 pF, surrounded by ice. After electroporation, cells were allowed to recover for 10 minutes on ice and then for 1 S minutes at room temperature. One milliliter growth medium (Iscove's Modified Dulbecco's Medium [IMDM]; Life Technologies) supplemented with penicillin/ streptomycin, L-glutamine, and 20% horse serum (JRH Biosciences, Lenexa, KS) was then added to each sample. The samples were spun at 380 X g for S minutes, and the pellet was resuspended in 3 mL of growth medium. Bone marrow cells after electroporation were grown in six-well, 35-mm plates for 3 days at 37°C in S% CO,.
These were then either assayed directly for hGH expression or immunomagnetically depleted of megakaryocytes and then assayed for hGH. The amount of DNA used for transfection, electroporation conditions, and culturing time posttransfection were based on preliminary titration experiments.
Rudioinzmumassuy. Nonadherent rat bone marrow cells were collected from the six-well plates 3 days posttransfection, washed with phosphate-buffered saline (138 mmol/L NaCl, 2.7 mmol/L KCI, 8.1 mmol/L Na2HP04.7H20, I .2 mmol/L KH2P04, pH 7.1), resuspended i n 0.3 mL dH,O, and lysed by freezing and thawing twice. Preliminary studies showed that only l % of the cells were adherent to the plates, and these cells do not express hGH above background levels. One hundred microliters of lysed cells was then assayed for hGH by radioimmunoassay according to the protocol provided by the manufacturer (Nichols Institute Diagnostics).
Hirt assay. The Hirt assayzy was used to determine the relative transfection efficiencies of the different plasmids tested, as described previously.22 To this end, electroporated, cultured marrow cells (0.7 mL) were lysed by incubation with 0.7 mL of Hirt solution (0.6% sodium dodecyl sulfate, 0.01 mol/L EDTA, and 7 pg/mL calf thymus DNA, pH 7.5) at 4°C. Control rGPTTb/pOGH plasmid DNA (175 ng) was added. This control contained a rGPIIb/hGH Bum-Sstl fragment of a different size compared with those constructs under study. After a 2-hour incubation, NaCl was then added to 1 mol/L and the For personal use only. on October 23, 2017. by guest www.bloodjournal.org From sample was incubated overnight at 4°C. The lysates were centrifuged at 7,000 X g for 20 minutes at 4"C, 0.5 mL of the supernatants were treated with DNase-free RNase (50 pg/mL), and the DNA was extracted with phenol-chloroform and chloroform, precipitated with 100% ethanol, and washed with 70% ethanol. After extraction and purification, the DNA was digested with Sstl and BamHI and quantitated by Southern blot analysis using the 500-bp BarnHVSstI fragment from hGH as a probe. Because this region is common to all constructs, we were able to examine simultaneously both the sample DNA fragment and the different-sized control DNA fragment on the same gel. An Ambis P-Analyzer (Ambis Systems, San Diego, CA) was used to quantitate the bands. The result of each hGH assay was then normalized to the quantitated sample DNA to account for transfection efficiency.
Demonstration of megakaryocyte-spec@ expression. The primary method used for the determination of megakaryocyte specificity of expression involved immunomagnetic separation of the electroporated marrow followed by reporter gene assay. Forty microliters of primary antibody (0.898 mg/mL), a mouse antirat GPIIbnIIa monoclonal antibody (a generous gift from Drs Takamoto Suzuki and Hiroshi Miyazaki3'), was added to 3-day posttransfection, electroporated, cultured marrow cells (4 X IO6 cells), then resuspended in 0.5 mL of modified growth medium (MGM) (IMDM; 5% horse serum, 1 mmoVL adenosine [Sigma, St Louis, MO], 2 mmoVL theophylline [Sigma]) and incubated for 45 minutes at room temperature on a gyrorotary platform. After incubation, the samples were washed twice with MGM. Iron beads (Dynal, Oslo, Norway) coated with rat antimouse IgG2a (4 X IO6, 10 pL) were then added. Before use, these iron beads had been washed three times with an equal volume of MGM. The samples were then incubated for 45 minutes at room temperature on the gyrorotary shaker. Each sample was then placed on the magnetic separator and the supernatant was removed. The samples were washed twice with MGM, saving both washes. The bead-negative, megakaryocyte-depleted samples (supernatant and washes) were then measured for hGH expression and compared with parallel samples, prepared in an identical fashion, except that they were not incubated with either the primary or secondary antibodies (total hGH expression in the transfected marrow). To check for nonspecific binding of cells to the secondary antibody-coated beads, marrow cells were transfected with the 912/pOGH construct and, just before the hGH expression assay, secondary antibody-coated beads only (no primary antibody) were added to the sample. The cells were then separated and assayed for hGH. It was determined that the efficiency of megakaryocyte separation with the immunomagnetic procedure was approximately 95% as judged by cornparison of this control (in which no primary antibody was added) to total hGH expression in the transfected marrow. For some constructs, megakaryocyte-specific expression was also determined by botrocetin agglutination of megakaryocyte^.^'
Computer and statistical analyses. Determined sequence was stored on DNAsis Pro (Hitachi, San Bruno, CA). Dot matrix comparison with the human GPIIb gene was performed using the following parameters: 20 nucleotide stretches with 13 nucleotide matches. Statistical comparison of expression levels between various constructs and the full-length, wild-type 912 construct were performed using StatView (Abacus Concepts, Berkeley, CA). Analysis was done using the Mann-Whitney test for nonparametric comparison between two means.32 We used transient expression experiments to identify functionally significant regulatory regions within these conserved domains of the rGPIIb gene 5'-flanking region. Nine hundred twelve base pairs of the 5"flanking region upstream from the transcriptional start site and the 32-bp 5'UT region were linked to the hGH gene, as described in the Materials and Methods, and served as the full-length, wild-type expression vector in the studies described below.
RESULTS

Identzjkation
Transient expression studies in primary rat bone marrow demonstrated that the 912 construct had approximately similar levels of hGH expression as the previously described PF4 5'-flanking region construct" (data not shown). To define cis-acting regulatory elements in this 5"flanking region, truncated constructs containing shorter lengths of the 5'-flanking region were generated using 5' primers for PCR amplification that were downstream of the -912 primer, following the same strategy as discussed above for the fulllength construct (Fig 2) . Rat bone marrow cells were transfected with these constructs. As shown in Fig 3A, there was a slight decrease in activity with the different constructs, gradually truncated to contain 460 bp upstream of the transcriptional start. However, a precipitous decrease in expression to the level of the promoterless vector (-1 % of wildtype, full-length) occurred with constructs containing 439 bp or less of the 5"flanking region. This suggested that the 21-bp region between -460 and -439 played an important role in the regulation of expression of the GPIIb gene.
Experiments were then performed to characterize further the domain between -460 and -439. A 912A construct, in which the -460 to -439 region of the ffiPIIb gene was deleted, had background levels of expression (Fig 3B) . Similarly, an additional truncated construct, beginning at base -453 immediately downstream of a GATA-binding consensus sequence, also had background levels of expression ( Fig  3B) . These constructs further localized this important regulatory element to a 7-bp region, containing a GATA-binding consensus sequence, which we have termed G A T h s 4 . Elimination of this region has a marked effect on expression.
Regulatory elements between -453 and the transcription start site. Because all of the 5"truncated constructs missing the GATLS4 element (containing < 454 bp of the 5'-flanking region) had background levels of expression, we were not able to determine whether other regions closer to the start site would affect expression. To test for additional elements, SO-bp deletions were made 3' to the GAT&s4 element in the full-length 912 construct, leaving the GATA4s4 intact, as depicted in Fig 4A. Most of the constructs expressed at greater than 30% of the wild-type construct. However, deletion constructs, with the bases between -450 and -401 and between -400 and -351 removed, had background levels of expression comparable to the promoterless vector.
We then constructed four substitutions in the full-length, of the full-length, wild-type, while the other three had approximately 68% activity (Fig 4B) . These data suggest that the region immediately downstream of the GAT&54 element, between -450 and -426, is important in the regulation of expression of the rGPIIb gene. As shown in Fig 4A, a deletion construct (100/51A), with the bases between -100 and -51 removed, had approximately 35% of wild-type expression levels. In addition, a deletion construct (50/-lA), with the bases from -50 to -1 removed, also had a low level of expression (7%). Of interest was the increased level of expression with 150/101A construct, which expressed at twice the level of the wildtype vector and over three times higher than any of the other deletional constructs. Such an increase in expression suggests that there may be a negative regulatory element in this region. This increase over the wild-type was statistically significant within 99% confidence limits.
Because elimination of the rat homologue of domain A, a region that contains a GATA-binding consensus sequence near -54, still had 35% of the wild-type expression, we wondered whether this GATAS4 element had promoter activity in our rat expression system. Elimination of the GATkS4 element in our truncation studies had a much more marked effect on expression, decreasing expression by 2 orders of 
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magnitude, while elimination of the GATA54 element in our 50-bp deletion constructs decreased expression by only threefold. Therefore, two point-mutation constructs were made: the GATA54 construct contains a G to C mutation at -54 in the full-length 912 construct, and the GAT&54 construct contains a similar change involving a C to G mutation at -454. These point mutations destroy the GATA binding sequence, because the G-A-T portion of the consensus sequence is important for GATA nuclear protein binding.33. 34 As expected, the mutated GATA,,, construct expressed at background levels ( Fig 4B) . However, the mutated GATA54 construct also expressed at low levels, approximately 11% of the full-length, wild-type construct (Fig 4B) . This suggested that this GATA-binding consensus sequence may also be an important element in promoting GPIIb expression. We also tested, by point mutation, whether either the Etsconsensus binding sequence at -512 and the complement Ets-consensus binding sequence at -35 affected expression. We mutated the consensus core GGAA sequence in these Ets-consensus binding sequences3, to GGIT in the fulllength, wild-type construct. This mutation eliminates the A/ C-G-G-A-A/T core Ets-consensus binding sequence. We found that the EtsSl2 mutation decreased expression to 32% of the full-length, wild-type (Fig 4B) . This level of decreased expression was consistent with our truncated constructs in which the 460 construct expressed at 55% of the 540 construct, which contained the Ehsl2 element, suggesting that elimination of the EhSl2 element was responsible for the decreased expression. The E~s~~ mutation construct ex- pressed at 5% of the full-length, wild-type construct (Fig  can be accounted for by the elimination of an Ets-consensus 4B), which was consistent with our deletional construct in binding sequence. PU.l, a member of the Ets family of tranwhich removal of the region between -50 and -1 decreased scription factors, has been shown to interact with TFIID." expression to 7%. Again, these data suggest that the deIt has been suggested that in TATA-less promoters, Ets procreased expression observed with the deletional construct teins binding in regions normally containing TATA boxes
Lineage-specijc expression of diflerent rGPllb gene constructs. These transient expression studies were performed with multilineage primary hematopoietic cells. It was therefore necessary to determine the specificity of hGH expression within the megakaryocytes found in this mixed hematopoietic source. Initial studies with the 670-bp construct, using botrocetin removal of megakaryocytes:' showed that greater than 93% of the hGH measured was expressed in megakaryocytes, similar to that seen with the PF4hGH expression vector when performed in parallel. This suggested that the GPIIb 5"flanking region was megakaryocyte-specific in its expression, similar to PF4.22 However, because of the limited availibility of purified botrocetin, we developed an alternative method for megakaryocyte separation. To this end, we devised an immunomagnetic separation protocol that was used to remove all GPIIbnIIa-positive cells from the remaining transfected marrow cells after 3 days in culture. Less than 1% of total cultured cells attached to the beads after immunomagnetic separation. Morphologic examination of these cells demonstmted that they were large megakaryocytes. No such large cells were present when the antirat GPIIbDIIa antibody was not included. Lineage specificity was determined for all the constructs that had greater than 10% expression of the full-length, wild-type 912 construct. With constructs demonstrating low levels of expression, less than 10% of the 912 construct, a high noise to signal ratio in immunomagnetic measurements prevented us from reliably determining lineage-specific expression. Expression of hGH in the GPIIb/IIIa-negative population of cells was compared with total, unseparated cells for the same construct. As shown in Fig 5 , all the constructs tested expressed 85% or greater of their reporter gene signal in megakaryocytes.
DISCUSSION
The data derived from our analyses of the 5"flanking region of the rGPIIb gene in a transient assay primary cell system are summarized in Fig lA, which compares our results with those derived for the human GPIIb gene based primarily on transient expression studies in HEL cells. The change in hGH expression resulting from elimination, deletion, or point mutations in defined regions are indicated. In general, our results corroborate some of the findings previously rep~rted.'.'~ Domains A, D, and E involve regions important for linage-specific expression of the GPIIb gene. However, a number of important quantitative differences were noted. In studies with HEL cells, the various promoter elements all had approximately equal effects on expression, decreasing expression threefold. In our studies, elimination of domain E, which contains the EtsSl2, decreased expression by twofold (Fig 1A) . In contrast, expression obtained with a mutation of the Ets-consensus site at -35 resulted in a 15-fold decrease in expression, as compared with a threefold decrease observed in the studies performed with the human homologue in HEL cells.' Moreover, deletion, truncation, or mutation of the GAT&54 element in the rat 5"flanking region in our primary rat marrow system decreased expression by approximately 50-fold (Fig 1A) . Thus, our studies clearly demonstrate, for the first time, the crucial role of this GATAbinding element at -454 in GPIIb expression. Mobility-shift studies using HEL cell nuclear extracts and a polyclonal anti-GATA-1 antibody suggest that GATA-1 binds to the GAT&54 site.37 Of interest, it appears that while GATA-1 is expressed during early megakaryocytopoiesis, this expression decreases with terminal differentiati~n.~'.~~ In contrast, GATA-2 is expressed in both megakaryocyte precursors and mature megakaryocyte^.^^ How these nuclear regulatory factors interact to result in high-level terminal expression of GPIIb remains to be elucidated. Also of interest is the finding that a GATA-binding consensus sequence at -3 1 in the PF4 gene promotes high-level tissue-specific expression of the PF4 gene in megakaryocytes and inhibits PF4 expression in other lineages.22.m Thus, primary hematopoietic expression studies of two different platelet-specific genes both imply an important role for GATA-binding proteins in megakaryocyte-specific gene regulation.
The GATAs4 binding element also affected expression. Its
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From deletion in the 100/51A construct resulted in a threefold decrease in expression, while a point mutation in this GATA site within the full-length 912 construct decreased expression ninefold. In contrast, mutation of the homologous GATAbinding element in the human studies had no effect within the full-length, wild-type construct, and only decreased expression sixfold when combined with a mutation in the domain D GATA-binding element. 37 The differences between the presented data and previous data on hGPIIb may be due to several reasons. Part of the difference may be caused by species differences, even though there is a high degree of sequence homology between rat and human GPIIb in these specific 5'-flanking regions, as illustrated in Fig 1B. The differences may also reflect the differences in the expression level of the full-length construct to which expression by the mutant constructs were compared. Previous publication^"^ used approximately 800 bp of the 5'-flanking region in their full-length expression construct. This is comparable to our 798 construct, which had only two thirds of the expression of our 912 construct ( Fig  3A) . However, this difference in full-length construct expression levels cannot account for the marked differences observed with the removal of important cis elements.
It is therefore likely that a significant portion of the quantitative differences in the importance of different cis elements demonstrated in the presented studies is due to the use of primary marrow cells undergoing normal differentiation into mature megakaryocytes, rather than cell lines such as HEL cells. HEL cells are aneuploidic, and while they exhibit some megakaryocytic features such as expressing GPIIb and platelet factor 4 (PF4);' the level of GPIIbDIIa complex and PF4 in HEL cells is low compared with those in platelets. Further, HEL cells do not express other megakaryocyte-specific genes such as Gz4* or PTG (unpublished observations), nor do they develop e-granules or a membrane demarcation system. They also express a number of erythroid-43 and macrophage-like" features, which may perturb expression levels of megakaryocytic genes.
In addition, our studies appear to have defined two new regulatory regions in the 5'-flanking region of the rGPIIb gene. One of these areas involves the region immediately downstream of the GATA4s4-binding element. Deletions in the -450 to -401 and the -400 to -351 regions greatly decreased expression. Noncomplementary 25-bp inversions in these regions suggest that the -450 to -426 region may contain a regulatory element. Further studies are needed to confirm these findings in that the noncomplementary inversions would preserve any simple repeated sequences and palindromic structures. Confirmation of the above findings would be of interest in that this region is immediately downstream of the GATLS4 element, which suggests that there may be interactions between these two sites. It has been shown that bound trans-acting GATA proteins may interact with other nearby regulatory complexes such as Spl, Ets, and transcription initiation c o m p l e~e s .~~~~~ Based on our deletional constructs, we note that the sequence between -150 and -101 bp upstream of the transcriptional start site may contain a negative regulatory element. Elimination of this sequence increases expression by threefold over other deletional constructs and twofold over the wild-type expression construct. A potential suppressor element containing a 26-bp stretch of pyrimidine residues has been described in the 5'-flanking region of the rPF4 gene." The -150 to -101 region contains a 13-bp pyrimidine stretch. Further studies are underway to define the minimal suppressor element and its role in the megakaryocytespecific nature of GPIIb expression.
In summary, our transient expression studies of the rGPIIb 5"flanking region in primary marrow cells demonstrate important features of the regulation of this gene (Fig 1A) . We show that the GATA,,, element is an extremely important regulatory region in the 5'-flanking region, capable of affecting GPIIb expression in megakaryocytes by 50-fold. In addition, the Ets3s has a significant effect on expression, as does the GATAS,. The EtsSl2 has only a minimal effect on expression. In addition, we show that a region from -4.50 to -426 may contain a positive regulatory element. If confirmed, it is possible that this region may interact with the GATA4s4 regulatory domain. Another regulatory region demonstrated by deletional constructs involves a potential silencer element from -150 to -101. Further characterization of these cisacting elements and the trans-acting factors that bind to these regions are underway and should elucidate the mechanisms by which megakaryocyte-specific expression is achieved for GPIIb. Such studies may be helpful to determine the mechanisms by which other lineage-specific genes are expressed during megakaryocytopoiesis. 
